These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6574949)

  • 1. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
    Thoene I; Kabisch H
    Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
    Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
    Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
    Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
    J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell surface markers of childhood leukemias and lymphomas].
    Shibuya A; Shinozawa T; Yoshikawa T; Katayama I
    Rinsho Ketsueki; 1985 Jan; 26(1):7-14. PubMed ID: 3158761
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypic characterization of 'non-T, non-B' acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies.
    Al-Katib A; Wang CY; Bardales R; Koziner B
    Hematol Oncol; 1985; 3(4):271-81. PubMed ID: 2417929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation antigens in acute leukaemia.
    Reen DJ
    Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of immunological and cytochemical profiles between adult and childhood acute lymphoblastic leukemias (ALLs): heterogeneity in adult common ALL.
    Kuriyama K; Tomonaga M; Nonaka H; Jinnai I; Matsuo T; Yoshida Y; Amenomori T; Tagawa M; Ichimaru M; Ohmiya A
    Leuk Res; 1985; 9(10):1237-47. PubMed ID: 2933563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of monoclonal-antibody phenotyping in childhood acute lymphoblastic leukemia.
    Kersey J; Goldman A; Abramson C; Nesbit M; Perry G; Gajl-Peczalska K; LeBien T
    Lancet; 1982 Dec; 2(8313):1419-23. PubMed ID: 6129506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
    Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163
    [No Abstract]   [Full Text] [Related]  

  • 12. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
    J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute lymphoblastic leukemia polymorphism disclosed by monoclonal antibodies.
    Leglise MC; Desfontaine B; Abgrall JF; Dutel JL; Le Roux AM; Vicariot M; Briere J
    Ric Clin Lab; 1984; 14(3):313-8. PubMed ID: 6335284
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
    Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
    Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of the immunological subvariants of acute lymphoblastic leukemia in children].
    Baryshnikov AIu; Lenskaia RV; Kondratchik KL; Tupitsyn NN; Baĭdun LV
    Gematol Transfuziol; 1987 Feb; 32(2):26-31. PubMed ID: 3493944
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and clinical significance of immunological cell markers in leukemia.
    Thiel E
    Recent Results Cancer Res; 1984; 93():102-58. PubMed ID: 6382477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute lymphoblastic leukemia and HLA].
    Qian FW; Ye GY; Kong FH
    Zhonghua Nei Ke Za Zhi; 1986 Apr; 25(4):217-9, 253-4. PubMed ID: 3461930
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA DR antigens in childhood acute lymphoblastic leukaemia long survival.
    De Bruyere M; Cornu G; Ninane J; Latinne D; Lebacq AM; Sokal G
    Br J Haematol; 1982 Aug; 51(4):659-61. PubMed ID: 6980667
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of acute leukemia with lympho- and myeloblastic blast cell characteristics].
    Tupitsyn NN; Baryshnikov AIu; Makhonova LA; Peterson IS; Morozova LF
    Gematol Transfuziol; 1984 Aug; 29(8):49-54. PubMed ID: 6332760
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain tumor-associated antigens.
    de Tribolet N; Carrel S; Mach JP
    Prog Exp Tumor Res; 1984; 27():118-31. PubMed ID: 6385122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.